Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIZANIDINE | 4MG | TABLET | Resolved | 2025-04-17 | 2025-06-17 | 255208 |
| APO-TOBRAMYCIN | 0.3% | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19123 |
| APO-TOLTERODINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-11-08 | 516 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2017-11-07 | 519 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2018-02-28 | 523 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-03-21 | 2017-03-21 | 3746 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2017-04-24 | 2017-07-05 | 7728 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-05-10 | 2017-05-25 | 9957 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-06-13 | 2017-07-11 | 12701 |
| APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2017-09-07 | 2017-10-16 | 21216 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-01 | 2018-01-03 | 27767 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2017-12-14 | 2018-03-06 | 32839 |
| APO-TOPIRAMATE | 200MG | TABLET | Resolved | 2018-03-29 | 2018-07-03 | 44200 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-05-08 | 2018-07-03 | 48869 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2018-11-09 | 2019-01-17 | 66552 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69324 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2019-04-24 | 2019-07-19 | 82340 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2019-05-15 | 2019-07-05 | 84163 |
| APO-TOPIRAMATE | 25MG | TABLET | Resolved | 2019-10-09 | 2019-12-02 | 95894 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2022-01-21 | 2022-02-18 | 153291 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |